Changes in cardiac function after effective treatment of hypertensive emergencies with i.v. clonidine

European Heart Journal
|December 1, 1984
PubMed

Insights

Intravenous clonidine effectively normalized blood pressure in patients with hypertensive emergencies, improving cardiac function and vascular resistance. This study highlights clonidine as a safe and effective treatment option for these critical conditions.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Hypertensive emergencies require prompt and effective blood pressure reduction.
  • Intravenous medications are often necessary for rapid control.

Purpose of the Study:

  • To evaluate the efficacy and safety of intravenous clonidine infusion for managing hypertensive emergencies.
  • To assess the impact of clonidine on hemodynamics and cardiac performance.

Main Methods:

  • 12 patients with hypertensive emergencies received escalating doses of intravenous clonidine infusion.
  • Blood pressure, vascular resistance, heart rate, and cardiac performance (ejection fraction, end-diastolic/systolic volumes) were monitored.
  • Radionuclide angiocardiography was used to assess cardiac function.

Main Results:

  • All patients achieved normalized blood pressure (mean BP ≤ 105 mmHg).
  • Clonidine reduced total and lower limb vascular resistance, with a transient decrease in heart rate.
  • Cardiac performance improved, evidenced by increased ejection fraction and reduced ventricular volumes.
  • Mean dose was 382.5 ± 98.3 mcg over 26.5 ± 4.6 minutes; side effects (dry mouth, drowsiness) were mild and transient.

Conclusions:

  • Intravenous clonidine is an effective and safe treatment for hypertensive emergencies.
  • It normalizes blood pressure while improving cardiac function and reducing vascular resistance.

Related Concept Videos

Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.0K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
2.1K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
2.9K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.7K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798